Hi, how are you doing?<\/p>\n
Both Evliplera and Delstrigo carry the same caution of being used in patients that have liver impairment. They are both to be avoided in those with severe impairment but can be used when the liver is working moderately well or better. As you have been on Evliplera, the caution remains the same if moving onto Delstrigo. Do you have an active hepatitis B infection?<\/p>\n
As you have mentioned costings, it is likely for this to be sole reason. The NHS operates on a cost effectiveness basis and unfortunately brexit will have had a hand in this. If you want to stay with Evliplera it is possible you could ask for the medication to be split into 2 pills instead of one as this would be cheaper, however it would require taking 2 pills per day instead of 1.<\/p>\n
Evliplera and Delstrigo are both effective and there is no risk to your health of switching. As you have been doing so well already on Evliplera it would be expected to continue this trend on Delstrigo. The benefit of being on Delstrigo is that you would be able to maintain taking only one pill per day.<\/p>\n
Have you been given any other reasons for why your doctor is suggesting that you switch?<\/p>\n
Josh.<\/p>\n","protected":false},"excerpt":{"rendered":"
Hello, I have been on Evliplera treatment for about 10 years and doing so well. I have been living in the UK for 5 years and it looks like they are trying to force me to change to Delstrigo as the Eviplera, after brexit for the NHS is too expensive.<\/p>\n
I\u2019m a bit scared as I don\u2019t want it to change, plus my first doctor in Italy told me as I had hepatitis B in the past I cannot have it.<\/p>\n
I would really appreciate if someone can give me an answer of what I could do .<\/p>\n
Many Thanks, <\/p>\n
Costa<\/p>\n","protected":false},"author":18,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4,5,7],"tags":[],"class_list":["post-19335","post","type-post","status-publish","format-standard","hentry","category-access-to-treatment","category-adherence","category-all-topics"],"_links":{"self":[{"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/posts\/19335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/comments?post=19335"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/posts\/19335\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/media?parent=19335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/categories?post=19335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/tags?post=19335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}